Titre :
|
Benefits and Effectiveness of Administering Pneumococcal Polysaccharide Vaccine With Seasonal Influenza Vaccine : An Approach for Policymakers. (2012)
|
Auteurs :
|
GILCHRIST (Shawn-An) : CAN. S Gilchrist Consulting Services. Brampton. ON. ;
LEVINE (Orin) : USA. International Vaccine Access Center. And International Health. Johns Hopkins Bloomberg School of Public Health. Baltimore. MD. ;
NANNI (Angeline) : USA. Aln Consulting. Ellicott City. MD.
|
Type de document :
|
Article
|
Dans :
|
American journal of public health (vol. 102, n° 4, 2012)
|
Pagination :
|
596-605
|
Langues:
|
Anglais
|
Mots-clés :
|
Efficacité
;
Vaccin
;
Prévention santé
;
Variation saisonnière
;
Grippe
;
Streptococcie
;
Bactériose
;
Infection
;
Bactérie
;
Virose
|
Résumé :
|
[BDSP. Notice produite par INIST-CNRS 8G9R0xCD. Diffusion soumise à autorisation]. For the influenza pandemic of 2009-2010, countries responded to the direct threat of influenza but may have missed opportunities and strategies to limit secondary pneumococcal infections. Delivering both vaccines together can potentially increase pneumococcal polysaccharide vaccine (PPV23) immunization rates and prevent additional hospitalizations and mortality in the elderly and other high-risk groups. We used PubMed to review the literature on the concomitant use of PPV23 with seasonal influenza vaccines. Eight of 9 clinical studies found that a concomitant program conferred clinical benefits. The 2 studies that compared the cost-effectiveness of different strategies found concomitant immunization to be more cost-effective than either vaccine given alone. Policymakers should consider a stepwise strategy to reduce the burden of secondary pneumococcal infections during seasonal and pandemic influenza outbreaks.
|